Communiqués Cencora, Inc.

Actions

COR

US03073E1055

Equipement, fournitures et distribution médicale

Marché Fermé - NYSE Autres places de cotation 22:00:03 21/07/2026			Après clôture 02:00:00
303,07 ^USD	-0,30%		298,46	-1,52%

21/07	CENCORA, INC. : BofA Securities réitère son opinion positive sur le titre	ZM
07/07	CENCORA, INC. : Evercore ISI conserve son opinion neutre	ZM

Communiqués

14/07	Cencora : World Courier Expands Cold Chain Capabilities \| Cencora	PU
01/07	Cencora Announces Date and Time for Third Quarter Fiscal 2026 Earnings Release	BU
15/06	Cencora Announces Samantha Hammock as Chief Human Resources Officer	BU
27/05	Cencora Appoints Eva Boratto as Executive Vice President and Chief Financial Officer	BU
21/05	Cencora Announces Updated Fiscal Year 2026 Financial Outlook	BU
06/05	Cencora : Q2 2026 Cencora Earnings Presentation	PU
06/05	Cencora: Fiscal Q2 Earnings Snapshot	AQ
06/05	Cencora Reports Fiscal 2026 Second Quarter Results	BU
24/04	Cencora : Pharmaceutical supply chain experts discuss the transition to the FDA’s new 12-digit NDC format with Drug Topics and Pharmaceutical Commerce	PU
24/04	RIS Rx Welcomes Industry Pioneer Tom Doyle as Senior Advisor	AQ
01/04	Cencora Announces Date and Time for Second Quarter Fiscal 2026 Earnings Release	BU
25/03	The Next Phase Of Vertical Integration: Wholesalers Follow The PBM Playbook	AQ
23/03	Cencora to Expand Retina Consultants of America Through Acquisition of EyeSouth Partners’ Retina Business	BU
18/03	Cencora Releases Fiscal Year 2025 Corporate Responsibility Report, Marking 10 Years of Purpose in Action	AQ
17/03	Cencora Announces Financial Leadership Transition	BU
09/03	Cencora : CDP Climate Change Disclosure	PU
06/03	Cencora : Human Rights Statement	PU
18/02	Covetrus and MWI Animal Health to Merge	BU
16/02	Cencora Closes $3.0 Billion Senior Notes Offering	AQ
13/02	Cencora Closes $3.0 Billion Senior Notes Offering	BU
10/02	Cencora Prices $500 Million 3.950% Senior Notes Due 2029, $500 Million 4.250% Senior Notes Due 2030, $500 Million 4.600% Senior Notes Due 2033, $1.0 Billion 4.900% Senior Notes Due 2036 and $500 Million 5.650% Senior Notes Due 2056	BU
09/02	Chief Executives for Corporate Purpose Announces Covista Chairman and CEO Steve Beard, Cencora Inc. Former Executive Chair Steven H. Collis, and Ann Fairchild, interim President and CEO of Siemens USA Joining Board of Directors	AQ
04/02	Cencora: Fiscal Q1 Earnings Snapshot	AQ
04/02	Cencora : First Quarter 2026 Presentation	PU
04/02	Cencora Reports Fiscal 2026 First Quarter Results	BU